Loading…
Reported covered position: Vice President, U.S. Professional Relations
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
SAFE Banking Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
SAFE Banking Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · third_quarter · 3A
FY2020 Omnibus Appropriations Bill - Issues related to patient safety, product regulations, and FDA enforcement; FDA regulation of cannabidiol in medicines and consumer products
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Source: Senate LDA
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Consolidated Appropriations Act, 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
2019 Consolidated Appropriations Act (H.R. 648) - Sections 536 & 537's impact on other agencies
Consolidated Appropriations Act, 2019
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
2019 Consolidated Appropriations Act (H.R. 648 - Sections 536 & 537's impact on other agencies; FY2020 Omnibus Appropriations Bill - Provisions related to patient safety, product regulations, and FDA enforcement
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
State Medicaid Waiver Flexibility Act of 2017
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
State Medicaid Waiver Flexibility Act of 2017
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Marijuana Revenue and Regulation Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Marijuana Revenue and Regulation Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Regulate Marijuana Like Alcohol Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Regulate Marijuana Like Alcohol Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Agriculture Improvement Act of 2018
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug H.R. 2 - Agriculture Improvement Act of 2018 - FDA's jurisdiction over hemp-derived CBD products
Agriculture Improvement Act of 2018
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Senate: S. 3042-Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
States' Medical Marijuana Property Rights Protection Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
States' Medical Marijuana Property Rights Protection Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Industrial Hemp Farming Act of 2017
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Industrial Hemp Farming Act of 2017
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Compassionate Access Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Compassionate Access Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Respect State Marijuana Laws Act of 2017
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Respect State Marijuana Laws Act of 2017
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Agriculture Improvement Act of 2018
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Senate: S. 3042-Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
Charlotte's Web Medical Access Act of 2017
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB1764: Scope of research provisions SB1803: Scope of research provisions HR 715 definition of CBD HR 2273: Definition of CBD
Compassionate Access Act
Client: GREENWICH BIOSCIENCES, INC. · Firm: GREENWICH BIOSCIENCES, INC.
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB1764: Scope of research provisions SB1803: Scope of research provisions HR 715 definition of CBD HR 2273: Definition of CBD
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · third_quarter · Q3
FY2020 Omnibus Appropriations Bill - Issues related to patient safety, product regulations, and FDA enforcement; FDA regulation of cannabidiol in medicines and consumer products
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA - Regulations to implement 2018 Farm Bill Provisions; 2019 Consolidated Appropriations Act - Sections 536 & 537's impact on other agencies; HR 3055 - Clarifying agency roles around Food, Drug and Cosmetic Act; HR1595 - Clarifying proposed definitions; Regulation of cannabis based medicines
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · second_quarter · Q2
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
2019 Consolidated Appropriations Act (H.R. 648) - Sections 536 & 537's impact on other agencies
FDA regulation of cannabidiol in medicines and consumer products
Filing targets: Agriculture, Dept of (USDA), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2019 · first_quarter · Q1
The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions
2019 Consolidated Appropriations Act (H.R. 648 - Sections 536 & 537's impact on other agencies; FY2020 Omnibus Appropriations Bill - Provisions related to patient safety, product regulations, and FDA enforcement
Filing targets: Agriculture, Dept of (USDA), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2018 · third_quarter · Q3
Senate: S. 3042-Agriculture Improvement Act of 2018 H.R. 2 - Agriculture Improvement Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2018 · second_quarter · Q2
Introduction of company and development of a FDA approved cannabinoid drug H.R. 2 - Agriculture Improvement Act of 2018 - FDA's jurisdiction over hemp-derived CBD products
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, SENATE
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2018 · first_quarter · 1A
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2018 · first_quarter · Q1
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB 1803: Definition of CBD HR 331: Definition of CBD HR 715: Definition of CBD HR 975: Definition of CBD HR 1277: Definition of CBD HR 1823: Definition of CBD HR 1841: Definition of CBD HR 2920: Definition of CBD HR 3530: Definition of CBD
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2017 · fourth_quarter · Q4
Introduction of company and development of a FDA approved cannabinoid drug SB 1008: Definition of CBD SB 1276: Definition of authorized medical research SB1764: Scope of research provisions SB1803: Scope of research provisions HR 715 definition of CBD HR 2273: Definition of CBD
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
GREENWICH BIOSCIENCES, INC. via GREENWICH BIOSCIENCES, INC.
2017 · fourth_quarter · RR
Pharmaceutical manufacturing and Healthcare
Pharmaceutical manufacturing and Healthcare
Pharmaceutical manufacturing and Healthcare
Pharmaceutical manufacturing and Healthcare
Pharmaceutical manufacturing and Healthcare